KalVista Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Gross in USD from Q4 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
KalVista Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q4 2013 to Q1 2024.
  • KalVista Pharmaceuticals, Inc. Deferred Tax Assets, Gross for the quarter ending April 30, 2024 was $60M, a 27.5% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $60M +$12.9M +27.5% Apr 30, 2024 10-K 2024-07-11
Q1 2023 $47M +$17.2M +57.9% Apr 30, 2023 10-K 2024-07-11
Q1 2022 $29.8M +$11.6M +63.6% Apr 30, 2022 10-K 2023-07-10
Q1 2021 $18.2M Apr 30, 2021 10-K 2022-07-07
Q4 2015 $28.8M +$9.42M +48.5% Dec 31, 2015 10-K 2016-03-30
Q4 2014 $19.4M +$5.16M +36.2% Dec 31, 2014 10-K 2016-03-30
Q4 2013 $14.3M Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.